Core Challenge: Many diseases (such as neurodegenerative diseases, hereditary heart diseases) lack ideal animal models or are difficult to obtain early-lesion human tissue samples for research.iPSC Solution: Reprogram patient-derived cells (such as skin fibroblasts or blood cells) into iPSCs, then directionally differentiate them into disease-related functional cells (such as neurons, cardiomyocytes). Construct in vitro disease models to dynamically and intuitively study the cellular and molecular mechanisms of disease occurrence and development, especially suitable for the study of rare diseases and complex genetic diseases.What We Provide: Patient-specific iPSC line establishment, directional differentiation services for disease-related cell types (neurons, cardiomyocytes, hepatocytes, etc.), phenotypic analysis support for disease models.